Corcept Therapeutics | CORT - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Alaunos Therapeutics USD 1.07M 215K 2023-06
ANI Pharmaceuticals USD 3.06M 580K 2026-09
Ardelyx USD 4.96M 642K 2026-06
Aurora Cannabis CAD 464K 234K 2026-06
BioMarin Pharmaceutical USD 55.63M 7.67M 2026-09
Bristol-Myers Squibb USD 403M 4M 2026-09
Canopy Growth CAD 12.68M 364K 2026-06
Corcept Therapeutics USD 1.03B 145.32M 2026-09
Eli Lilly USD 316M 201.3M 2026-09
J&J USD 43M 25M 2026-03
Knight Therapeutics CAD 3.92M 1.56M 2025-12
Lexicon Pharmaceuticals USD 2.03M 124K 2025-12
Merck USD 525M 46M 2026-06
Nektar Therapeutics USD 7.94M 1.83M 2026-03
Novartis USD 468M 6M 2026-09
Novartis USD 281M 8M 2025-09
Omeros USD 4.05M 5.16M 2024-09
Pacira USD 112.4M 108.78M 2026-09
Pfizer USD 662M 5M 2026-09
Supernus Pharmaceuticals USD 718K 1.6M 2026-09
TG Therapeutics USD 15.82M 753K 2026-09